Private company

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

Fund registered in the Cayman Islands, based in Boston, active since 2019. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersBoston, United States²
Legal formexempted limited partnership²
Kind of organizationFund²
LEI549300WZRTOETY75LD02²
StatusActive²
LEI statusIssued and current²
Registered address89 Nexus Way, KY1-9009 Grand Cayman, Cayman Islands²
Registered withGeneral Registry, 101856²

See how the biggest companies compare on our leaderboards

Corporate structure

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Boston, Massachusetts, United States
- Aligos Therapeutics, Inc. Stake · South San Francisco, California, United States
- Verve Therapeutics, Inc. Stake · Boston, Massachusetts

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.

Timeline

May 23, 2019Founded Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is founded²

Stakes it holds

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).

Aligos Therapeutics, Inc.SC 13G/A Feb 4, 2022³
Verve Therapeutics, Inc.SC 13G/A Feb 4, 2022⁴

Sources

The numbers on this page point here. Each one links to the record it came from.